Showing results (61-70 of 81) with videos related to
Sort By:
Pageof 9
Lung Cancer (Amsterdam, Netherlands)|September 4, 2007
Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinibYoshiro Fujiwara, Katsuyuki Kiura, Shinichi Toyooka, et al.American Journal of Physiology. Lung Cellular and Molecular Physiology|October 17, 2015
Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsivenessAkihiko Taniguchi, Nobuaki Miyahara, Koichi Waseda, et al.Springerplus|August 21, 2014
Complete resolution of steroid-resistant organizing pneumonia associated with myelodysplastic syndrome following allogeneic hematopoietic cell transplantationTakeru Asano, Nobuharu Fujii, Daigo Niiya, et al.Respiratory Research|January 22, 2013
IL-17A is essential to the development of elastase-induced pulmonary inflammation and emphysema in miceEtsuko Kurimoto, Nobuaki Miyahara, Arihiko Kanehiro, et al.Respiratory Investigation|February 28, 2020
Deterioration of high-resolution computed tomography findings predicts disease progression after initial decline in forced vital capacity in idiopathic pulmonary fibrosis patients treated with pirfenidoneHisao Higo, Nobuaki Miyahara, Akihiko Taniguchi, et al.Arerugi = [Allergy]|February 21, 2012
[The relationships between the peak inspiratory flow and the characteristics factors in the asthmatics with inhaled corticosteroid -a multicenter study in Chugoku Shikoku area]Yasushi Obase, Arihiko Kanehiro, Yasushi Tanimoto, et al.International Archives of Allergy and Immunology|November 16, 2007
Growth factors temporally associate with airway responsiveness and inflammation in allergen-exposed miceWataru Ito, Mitsune Tanimoto, Katsuichiro Ono, et al.Cancer Journal (Sudbury, Mass.)|November 2, 2005
Interstitial lung disease in Japanese patients with non-small cell lung cancer receiving gefitinib: an analysis of risk factors and treatment outcomes in Okayama Lung Cancer Study GroupKatsuyuki Hotta, Katsuyuki Kiura, Masahiro Tabata, et al.Journal of Clinical Medicine|August 26, 2023
Switching to Dupilumab from Other Biologics without a Treatment Interval in Patients with Severe Asthma: A Multi-Center Retrospective StudyHisao Higo, Hirohisa Ichikawa, Yukako Arakawa, et al.Plos One|October 26, 2023
A randomized controlled trial of teprenone in terms of preventing worsening of COVID-19 infectionEiki Ichihara, Kou Hasegawa, Kenichiro Kudo, et al.Pageof 9